Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: A retrospective evaluation of subsequent pregnancies

Reproductive BioMedicine Online

Volumn 32, Issue 3, 2016, Pages 299-307

  Hamy, Anne Sophie ^a   Porcher, Raphaël ^b,c   Eskenazi, Sarah ^a   Cuvier, Caroline ^a   Giacchetti, Sylvie ^a   Coussy, Florence ^a   Hocini, Hamid ^a   Tournant, Bertrand ^a   Perret, Francine ^a   Bonfils, Sylvie ^a   Charvériat, Patrick ^a   Lacorte, Jean Marc ^c,d   Espie, Marc ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c INSERM   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

anti M llerian hormone; breast cancer; chemotherapy; pregnancy

Indexed keywords

ANTHRACYCLINE; MUELLERIAN INHIBITING FACTOR; TAXANE DERIVATIVE; TRASTUZUMAB; BRIDGED COMPOUND; TAXANE; TAXOID;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INDUCED ABORTION; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVARIAN RESERVE; OVARIECTOMY; OVERALL SURVIVAL; PARTHENOGENESIS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; ADOLESCENT; BLOOD; BREAST NEOPLASMS; FERTILITY PRESERVATION; PREGNANCY RATE; SURVIVAL ANALYSIS;

ADOLESCENT; ADULT; ANTHRACYCLINES; ANTI-MULLERIAN HORMONE; BREAST NEOPLASMS; BRIDGED-RING COMPOUNDS; DISEASE-FREE SURVIVAL; FEMALE; FERTILITY PRESERVATION; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAXOIDS;

EID: 84959358475     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2015.12.008     Document Type: Article

References (41)

1. C. Anders, P.K. Marcom, B. Peterson, Gu L., S. Unruhe, R. Welch, P. Lyons, M. Behera, S. Copland, G. Kimmick, H. Shaw, S. Snyder, M. Antenos, T. Woodruff, and K. Blackwell A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer Cancer Invest 26 2008 286 295 10.1080/07357900701829777
2. R.A. Anderson, and D.A. Cameron Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer J. Clin. Endocrinol. Metab 96 2011 1336 1343 10.1210/jc.2010-2582
3. R.A. Anderson, A.P.N. Themmen, A.A. Qahtani, N.P. Groome, and D.A. Cameron The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer Hum. Reprod 21 2006 2583
4. A.A. Azim, M. Costantini-Ferrando, and K. Oktay Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol 26 2008 2630 2635 10.1200/JCO.2007.14.8700
5. M.F.H. Brougham, P.M. Crofton, E.J. Johnson, N. Evans, R.A. Anderson, and W.H.B. Wallace Anti-mullerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study J. Clin. Endocrinol. Metab 97 2012 2059 2067 10.1210/jc.2011-3180
6. Chai J., A.F. Howie, D.A. Cameron, and R.A. Anderson A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer Eur. J. Cancer 50 2014 2367 2374 10.1016/j.ejca.2014.06.011
7. C. Decanter, M. Peigne, A. Mailliez, F. Morschhauser, A. Dassonneville, D. Dewailly, and P. Pigny Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay Fertil. Steril 102 2014 483 487 10.1016/j.fertnstert.2014.05.014
8. K.E. Dillon, M.D. Sammel, M. Prewitt, J.P. Ginsberg, D. Walker, J.E. Mersereau, Y. Gosiengfiao, and C.R. Gracia Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy Fertil. Steril 99 2013 477 483 10.1016/j.fertnstert.2012.09.039
9. P. Grambsch, and T. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 1994 515 556
10. C.P. Hagen, S. Vestergaard, A. Juul, N.E. Skakkebæk, A.-M. Andersson, K.M. Main, N.H. Hjøllund, E. Ernst, J.P. Bonde, R.A. Anderson, and T.K. Jensen Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study Fertil. Steril 98 2012 1602 1608.e2 10.1016/j.fertnstert.2012.08.008
11. H. Hamre, C.E. Kiserud, E. Ruud, P.M. Thorsby, and S.D. Fosså Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study Pediatr. Blood Cancer 59 2012 271 277 10.1002/pbc.23363
12. A.-S. Hamy, R. Porcher, C. Cuvier, S. Giacchetti, M.-H. Schlageter, C. Coussieu, H. Gronier, J.-P. Feugeas, N. Adoui, J.-M. Lacorte, C. Poirot, M. Habdous, and M. Espié Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone Reprod. Biomed. Online 29 2014 573 580 10.1016/j.rbmo.2014.07.008
13. Han H.-S., J. Ro, K.S. Lee, B.-H. Nam, J.A. Seo, D.H. Lee, H. Lee, E.S. Lee, Kang H.S., and S.W. Kim Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer Breast Cancer Res. Treat 115 2009 335 342 10.1007/s10549-008-0071-9
14. N.L. Henry, Xia R., A.F. Schott, D. McConnell, M. Banerjee, and D.F. Hayes Prediction of Postchemotherapy Ovarian Function Using Markers of Ovarian Reserve Oncologist 19 2014 68 74 10.1634/theoncologist.2013-0145
15. A. Ives, C. Saunders, M. Bulsara, and J. Semmens Pregnancy after breast cancer: population based study BMJ 334 2007 194 10.1136/bmj.39035.667176.55
16. J. Kalbfleisch, and R. Prentice The Statistical Analysis of Failure Time Data 1980 John Wiley Sons Inc N. Y 10.2307/3315078
17. N. Kroman, M.B. Jensen, J. Wohlfahrt, and B. Ejlertsen Pregnancy after treatment of breast cancer-a population-based study on behalf of Danish Breast Cancer Cooperative Group Acta Oncol 47 2008 545 549
18. A. Latouche, A. Allignol, J. Beyersmann, M. Labopin, and J.P. Fine A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions J. Clin. Epidemiol 66 2013 648 653 10.1016/j.jclinepi.2012.09.017
19. J.M. Letourneau, E.E. Ebbel, P.P. Katz, K.H. Oktay, C.E. McCulloch, Ai W.Z., A.J. Chien, M.E. Melisko, M.I. Cedars, and M.P. Rosen Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer Cancer 118 2012 1933 1939 10.1002/cncr.26403
20. A.W. Loren, P.B. Mangu, L.N. Beck, L. Brennan, A.J. Magdalinski, A.H. Partridge, G. Quinn, W.H. Wallace, K. Oktay American Society of Clinical Oncology Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol 31 2013 2500 2510 10.1200/JCO.2013.49.2678
21. K. Lutchman Singh, S. Muttukrishna, R.C. Stein, H.H. McGarrigle, A. Patel, B. Parikh, N.P. Groome, M.C. Davies, and R. Chatterjee Predictors of ovarian reserve in young women with breast cancer Br. J. Cancer 96 2007 1808 1816 10.1038/sj.bjc.6603814
22. M. Martin, T. Pienkowski, J. Mackey, M. Pawlicki, J.-P. Guastalla, C. Weaver, E. Tomiak, T. Al-Tweigeri, L. Chap, E. Juhos, R. Guevin, A. Howell, T. Fornander, J. Hainsworth, R. Coleman, J. Vinholes, M. Modiano, T. Pinter, Tang S.C., B. Colwell, C. Prady, L. Provencher, D. Walde, A. Rodriguez-Lescure, J. Hugh, C. Loret, M. Rupin, S. Blitz, P. Jacobs, M. Murawsky, A. Riva, and C. Vogel Adjuvant docetaxel for node-positive breast cancer N. Engl. J. Med 352 2005 2302 2313 10.1056/NEJMoa043681
23. H.C.F. Moore, J.M. Unger, K.-A. Phillips, F. Boyle, E. Hitre, D. Porter, P.A. Francis, L.J. Goldstein, H.L. Gomez, C.S. Vallejos, A.H. Partridge, S.R. Dakhil, A.A. Garcia, J. Gralow, J.M. Lombard, J.F. Forbes, S. Martino, W.E. Barlow, C.J. Fabian, L. Minasian, F.L. Meyskens, R.D. Gelber, G.N. Hortobagyi, K.S. Albain POEMS/S0230 Investigators Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy N. Engl. J. Med 372 2015 923 932 10.1056/NEJMoa1413204
24. K. Oktay, V. Turan, G. Bedoschi, F.S. Pacheco, and F. Moy Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol 33 2015 2424 2429 10.1200/JCO.2014.59.3723
25. A.H. Partridge, S. Gelber, J. Peppercorn, E. Ginsburg, E. Sampson, R. Rosenberg, M. Przypyszny, and E.P. Winer Fertility and menopausal outcomes in young breast cancer survivors Clin. Breast Cancer 8 2008 65 69
26. A.H. Partridge, K.J. Ruddy, S. Gelber, L. Schapira, M. Abusief, M. Meyer, and E. Ginsburg Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer Fertil. Steril 94 2010 638 644 10.1016/j.fertnstert.2009.03.045
27. J.A. Pérez-Fidalgo, S. Roselló, E. García-Garré, E. Jordá, P. Martín-Martorell, B. Bermejo, I. Chirivella, C. Guzman, and A. Lluch Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens Breast Cancer Res. Treat 120 2010 245 251 10.1007/s10549-009-0426-x
28. F.A. Peccatori, H.A. Azim, R. Orecchia, H.J. Hoekstra, N. Pavlidis, V. Kesic, and G. Pentheroudakis Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann. Oncol 24 2013 vi160 vi170 10.1093/annonc/mdt199
29. M. Peigné, and C. Decanter Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review Reprod. Biol. Endocrinol 12 2014 26
30. Pregnancy and Breast Cancer (Green-top Guideline No. 12) [WWW Document]; R. Coll. Obstet. Amp Gynaecol. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg12/ 2011 accessed 9.30.14
31. R Development Core Team R: A Language and Environment for Statistical Computing 2011 R Foundation for Statistical Computing
32. E.E. Rippy, I.F. Karat, and M.W. Kissin Pregnancy after breast cancer: the importance of active counselling and planning Breast 18 2009 345 350 10.1016/j.breast.2009.08.003
33. M. Rosendahl, C.Y. Andersen, E. Ernst, L.G. Westergaard, P.E. Rasmussen, A. Loft, and A.N. Andersen Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study Hum. Reprod 23 2008 2475 2483 10.1093/humrep/den248
34. M. Rosendahl, C.Y. Andersen, N. la Cour Freiesleben, A. Juul, K. Løssl, and A.N. Andersen Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age Fertil. Steril 94 2010 156 166 10.1016/j.fertnstert.2009.02.043
35. Su H.-C.I., C. Haunschild, K. Chung, S. Komrokian, S. Boles, M.D. Sammel, and A. DeMichele Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients Cancer 2014 10.1002/cncr.28942
36. Su H.I., M.D. Sammel, J. Green, L. Velders, C. Stankiewicz, J. Matro, E.W. Freeman, C.R. Gracia, and A. DeMichele Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors Cancer 116 2010 592 599
37. Su H.I., M.D. Sammel, M.V. Homer, K. Bui, C. Haunschild, and F.Z. Stanczyk Comparability of antimüllerian hormone levels among commercially available immunoassays Fertil. Steril 101 2014 1766 1772.e1 10.1016/j.fertnstert.2014.02.046
38. P. Sukumvanich, L.D. Case, K. Van Zee, S.E. Singletary, E.D. Paskett, J.A. Petrek, E. Naftalis, and M.J. Naughton Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study Cancer 116 2010 3102 3111 10.1002/cncr.25106
39. The Society of Obstetricians and Gynaecologists of Canada Breast cancer, pregnancy, and breastfeeding 2002
40. M. Wong, S. O'Neill, G. Walsh, and I.E. Smith Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: menstruation and pregnancy outcomes Ann. Oncol 24 2013 133 138 10.1093/annonc/mds250
41. Yu B., N. Douglas, M.J. Ferin, G.S. Nakhuda, K. Crew, R.A. Lobo, and D.L. Hershman Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy Cancer 116 2010 2099 2105